🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccha...
Status
Completed
Location
FUNCEI, French 3085
Start Date
2006-05
Trial ID
NCT00329849
Treatments Being Tested
To evaluate the safety and immune response of Novartis MenACWY conjugate va...
Status
Completed
Location
Children's Investigational Reserach Program
Start Date
2008-03
Trial ID
NCT00616421
Treatments Being Tested
This study will evaluate the lot to lot consistency, safety and immune resp...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00450437
Treatments Being Tested
MenACWY (Menveo) is a GSK vaccine intended for protection against disease c...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-08-30
Trial ID
NCT03433482
Treatments Being Tested
This study will evaluate the safety and immune response of Novartis Meningo...
Status
Completed
Location
Buenos Aires, Argentina
Start Date
2007-05
Trial ID
NCT00474487
The purpose of the study is to evaluate and compare the immune response to ...
Status
Completed
Location
University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2009-06
Trial ID
NCT00901940
The primary objective is to evaluate the persistence of bactericidal antibo...
Status
Completed
Location
37, 50 Birmingham Pediatric Associates 806 Saint Vincent's Drive, Suite 615
Start Date
2009-02
Trial ID
NCT00856297
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of N...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00262041
The primary objective is to evaluate the persistence of bactericidal antibo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01018732
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of N...
Status
Completed
Location
Kaiser Permanente Vaccine Study Center
Start Date
2005-04
Trial ID
NCT00262028
Treatments Being Tested